The National Institute of Neurological Disorders and Stroke (NINDS) is offering a grant to support translational and early feasibility studies for therapeutic devices targeting neurological disorders. This program aims to facilitate the development of clinical prototype devices, preclinical testing, and regulatory approval processes to progress towards a Pre-Market Approval or Humanitarian Device Exemption. Applicants will receive funding through cooperative agreements to pursue Investigational Device Exemptions, followed by Early Feasibility Studies with potential advancement to full Feasibility Studies and Pivotal Trials. Closing date for applications is May 07, 2017.
Opportunity ID: 260437
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-14-298 |
Funding Opportunity Title: | NINDS CREATE Devices: Translational and Early Feasibility Studies on the Path to Pre-Market Approval (PMA) or Humanitarian Device Exemption (HDE) (UH2/UH3) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jul 28, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | May 07, 2017 |
Current Closing Date for Applications: | May 07, 2017 |
Archive Date: | Jun 07, 2017 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Independent school districts City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments County governments For profit organizations other than small businesses Private institutions of higher education Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and Early Feasibility Studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement mechanism to support the submission of an Investigational Device Exemption (IDE), with the option of also supporting the following Early Feasibility Study. It is expected the immediate next steps upon completion of the Early Feasibility Study will be a full Feasibility Study and a Pivotal Trial in support of a PMA (Pre-Market Approval) or HDE (Humanitarian Device Exemption). Activities supported in this program include implementation of clinical prototype devices, preclinical safety and efficacy testing, design verification and validation activities, pursuit of regulatory approval for the clinical study, and an Early Feasibility Study. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-14-298.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-C | FORMS-C | PKG00201888 | Sep 21, 2014 | Jun 07, 2016 | View | |
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00223979 | Jul 11, 2016 | May 07, 2017 | View |
Package 1
Mandatory forms
260437 RR_SF424_2_0-2.0.pdf
260437 PHS398_ResearchPlan_2_0-2.0.pdf
260437 PHS398_CoverPageSupplement_2_0-2.0.pdf
260437 RR_Budget_1_3-1.3.pdf
260437 RR_KeyPersonExpanded_2_0-2.0.pdf
260437 RR_OtherProjectInfo_1_3-1.3.pdf
260437 PerformanceSite_2_0-2.0.pdf
Optional forms
260437 PlannedReport-1.0.pdf
260437 PHS398_CumulativeInclusionReport-1.0.pdf
260437 RR_SubawardBudget30_1_3-1.3.pdf
Package 2
Mandatory forms
260437 RR_SF424_2_0-2.0.pdf
260437 PHS398_CoverPageSupplement_3_0-3.0.pdf
260437 RR_OtherProjectInfo_1_3-1.3.pdf
260437 PerformanceSite_2_0-2.0.pdf
260437 RR_KeyPersonExpanded_2_0-2.0.pdf
260437 RR_Budget_1_3-1.3.pdf
260437 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
260437 RR_SubawardBudget30_1_3-1.3.pdf
260437 PHS_Inclusion_Enrollment_Report-1.0.pdf
260437 PHS_AssignmentRequestForm-1.0.pdf